G 367 Pill - beige gray capsule-shape
Pill with imprint G 367 is Beige / Gray, Capsule-shape and has been identified as Topiramate Extended-Release 25 mg. It is supplied by Glenmark Pharmaceuticals Inc.
Topiramate is used in the treatment of Migraine Prevention; Lennox-Gastaut Syndrome; Seizure Prevention; Seizures; Epilepsy and belongs to the drug class carbonic anhydrase inhibitor anticonvulsants. There is positive evidence of human fetal risk during pregnancy. Topiramate 25 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for G 367
Topiramate Extended-Release
- Imprint
- G 367
- Strength
- 25 mg
- Color
- Beige / Gray
- Shape
- Capsule-shape
- Availability
- Prescription only
- Drug Class
- Carbonic anhydrase inhibitor anticonvulsants
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Glenmark Pharmaceuticals Inc.
- National Drug Code (NDC)
- 68462-0372
Related images for "G 367"
More about topiramate
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1,314)
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- Support group
- Drug class: carbonic anhydrase inhibitor anticonvulsants
- Breastfeeding
Patient resources
- Topiramate drug information
- Topiramate (Advanced Reading)
- Topiramate Tablets
- Topiramate Extended-Release Capsules
- Topiramate Extended-Release Sprinkle Capsules
- Topiramate Sprinkle Capsules
Other brands
Topamax, Trokendi XR, Topamax Sprinkle, Eprontia, ... +2 more
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.